Biology of anchoring fibrils: Lessons from dystrophic epidermolysis bullosa

Matrix Biology

Volumn 18, Issue 1, 1999, Pages 43-54

  Bruckner Tuderman, Leena ^a   Höpfner, Bianca ^a   Hammami Hauasli, Nadja ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Basement membrane; Blistering; Collagen VII; Dermal epidermal

Indexed keywords

COLLAGEN TYPE 7; POLYMER;

AMINO ACID SUBSTITUTION; BASEMENT MEMBRANE; CELL ULTRASTRUCTURE; CYTOSKELETON; DERMOEPIDERMAL JUNCTION; EPIDERMIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EXTRACELLULAR MATRIX; GENE DELETION; GENE MUTATION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0345517972     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)00007-9     Document Type: Article

References (75)

1. Amano S., Takahara K., Gerecke D.R., Nishiyama T.et al. The gamma 2 chain of laminin 5 is processed BMP-1 and processing is essential to basement membrane assembly in vivo. J. Invest. Dermatol. (abstract). 108:1997;542.
2. Aumailley, M., Rousselle, P., this issue. Laminins of the Dermo-Epidermal Junction.
3. Bächinger H.P., Morris N.P., Lunstrum G.P.et al. The relationship of the biophysical and biochemical characteristics of type VII collagen to the function of anchoring fibrils. J. Biol. Chem. 265:1990;10095-10101.
4. Borradori L., Koch P.J., Niessen C.M., Erkeland S., van Leusden M.R., Sonnenberg A. The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit. J. Cell Biol. 136:1997;1333-1347.
5. Bruckner-Tuderman, L., 1993. Epidermolysis bullosa. In: Royce, P.M., Steinmann (Eds.), Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects. Wiley-Liss Inc, New York, pp. 507-532.
6. Bruckner-Tuderman L., Schnyder U.W., Winterhalter K.W., Bruckner P. Tissue form of type VII collagen from human skin and fibroblasts in culture. Eur. J. Biochem. 165:1987;607-611.
7. Bruckner-Tuderman L., Mitsuhashi Y., Schnyder U.W., Bruckner P. Anchoring fibrils and type VII collagen are absent from skin severe recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 93:1989;3-9.
8. Bruckner-Tuderman L., Nilssen Ö., Zimmerman D.et al. Immunohistochemical and mutation analysis demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J. Cell Biol. 131:1995;551-559.
9. Bruckner-Tuderman L., Bruckner P. Genetic diseases of the extracellular matrix: more than just connective tissue disorders. J. Mol. Med. 76:1998;226-237.
10. Burgeson R.E. Type VII collagen, anchoring fibrils and epidermolysis bullosa. J. Invest. Dermatol. 101:1993;252-255.
11. Burgeson R.M., Christiano A.M. The dermal-epidermal junction. Curr. Opin. Cell Biol. 9:1997;651-658.
12. Chen M., Goyal S., Cai X., O'Toole E.A., Woodley D.T. Modulation of type VII collagen (anchoring fibril) expression by retinoids in human skin cells. Biochim. Biophys. Acta. 1351:1997;333-340.
13. Chen M., Petersen M.J., Li H.L., Cai X., O'Toole E.A., Woodley D.T. Ultraviolet A irradiation upregulates type VII collagen expression in human dermal fibroblasts. J. Invest. Dermatol. 108:1997;125-128.
14. Chen M., Marinkovich P.M., Veis A.et al. Interaction of the aminoterminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. J. Biol. Chem. 272:1997;14516-14522.
15. Chen M., O'Toole E.A., Sanghavi J., Mahmud N., Kelleher D., Woodley D.T. Type VII (anchoring fibril) collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J. Invest. Dermatol. (abstract). 108:1997;542.
16. Christiano A.M., Greenspan D.S., Hoffmann G.G.et al. A missense mutation in type VII collagen in recessive dystrophic epidermolysis bullosa. Nat. Genet. 4:1993;62-66.
17. Christiano A.M., Hoffman G.G., Chung-Honet L.C.et al. Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics. 21:1994;169-179.
18. Christiano A.M., Greenspan D.S., Seungbok L., Uitto J. Cloning of human type VII collagen. Complete primary sequence of the α1(VII) chain and identification of intragenic polymorphisms. J. Biol. Chem. 269(VII):1994;20256-20262.
19. Christiano A.M., McGrath J.A., Tan K.C., Uitto J. Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. Am. J. Hum. Genet. 58:1996;671-681.
20. Christiano A.M., Fine J.-D., Uitto J. Genetic basis of dominantly inherited transient bullous dermolysis of the newborn: a splice site mutation in the type VII collagen gene. J. Invest. Dermatol. 109:1997;811-814.
21. Cui Y., Hagan K.W., Zhang S., Peltz S.W. Identification and characterization of genes that are required for the accelerated degradation of mRNA containing a premature translational termination codon. Genes Dev. 9:1995;423-436.
22. Dunnill M.G., McGrath J.A., Richards A.J.et al. Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 107:1996;171-177.
23. Eckes B., Scharffetter-Kochanek K., Wlaschek M., Krieg T. Connective tissue regulation in tissue repair and fibrosis. Curr. Opin. Dermatol. 4:1997;276-281.
24. Ekblom P., Ekblom M., Fecker L.et al. Role of mesenchymal nidogen for epithelial morphogenesis in vitro. Development. 120:1994;2003-2014.
25. Ekblom P., Timpl R. Cell-to-cell contact and extracellular matrix. A multifaceted approach emerging. Curr. Opin. Cell Biol. 8:1996;599-601.
26. Fleischmajer R., Utani A., MacDonald E.D. IIet al. Initiation of skin basement membrane formation at the epidermo-dermal interface involves assembly of laminins through binding to cell membrane receptors. J. Cell Sci. 111:1998;1929-1940.
27. Gammon W.R. Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen. J. Autoimmun. 4:1991;59-71.
28. Gardella R., Belletti L., Zoppi N., Marini D., Barlati S., Colombi M. Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the Localisata variant of recessive dystrophic epidermolysis bullosa. Am. J. Hum. Genet. 59:1996;292-300.
29. Gayraud B., Höpfner B., Jassim A., Aumailley M., Bruckner-Tuderman L. Characterization of a 50 kD component of epithelial basement membranes using the GDA-J/F3 monoclonal antibody. J. Biol. Chem. 272:1997;9531-9538.
30. Gedde-Dahl, T. Jr., Anton-Lamprecht, I., 1996. Epidermolysis bullosa. In: Rimoin, D.L., Connor, J.M., Pyeritz, R.E. (Eds.), Emery and Rimoińs Principles and Practice of Medical Genetics. Churchill Livingstone, New York, Vol. 1, pp. 1225-1278.
31. Goldsmith L.A., Briggaman R.A. Monoclonal antibodies to anchoring fibrils for the diagnosis of epidermolysis bullosa. J. Invest. Dermatol. 81:1983;464-466.
32. Hammami-Hauasli N., Schumann H., Raghunath M.et al. Some but not all glycine substitution mutations in COL7A1 result in intracellular accumulation of collagen VII, loss of anchoring fibrils and skin blistering. J Biol. Chem. 273:1998;19228-19234.
33. Hammami-Hauasli N., Raghunath M., Küster W., Bruckner-Tuderman L. Transient bullous dermolysis of the newborn associated with compound heterozygosity for recessive and dominant COL7A1 mutations. J. Invest. Dermatol. 111:1998;1214-1219.
34. Hilal L., Rochat A., Duquesnoy P.et al. A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nat. Genet. 5:1993;287-293.
35. Hovnanian A., Rochat A., Bodemer C.et al. Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am. J. Hum. Genet. 61:1997;599-610.
36. Jassim A., Schofield O., Whitehead P.et al. Detection of a novel basement membrane antigen by GDA-J/F3 anti-human sperm fibrous sheath monoclonal antibody. Br. J. Dermatol. 125:1991;101-107.
37. Keene D.R., Sakai L.Y., Lunstrum G.P., Morris N.P., Burgeson R.E. Type VII collagen forms an extended network of anchoring fibrils. J. Cell Biol. 104:1987;611-621.
38. Keene D.R., Marinkovich M.P., Sakai L.Y. Immunodissection of the connective tissue matrix in human skin. Microsc. Res. Technol. 38:1997;394-406.
39. Kessler E., Takahara K., Biniaminov L., Brusel M., Greenspan D. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science. 271:1996;360-362.
40. Khavari P. Gene therapy for genetic skin disease. J. Invest. Dermatol. 110:1998;462-467.
41. König A., Bruckner-Tuderman L. Transforming growth factor-β stimulates collagen VII expression by cutaneous cells in vitro. J. Cell Biol. 117:1992;679-685.
42. König A., Bruckner-Tuderman L. Transforming growth factor-β promotes deposition of collagen VII in a modified organotypic skin model. Lab. Invest. 70:1994;203-209.
43. Kuivaniemi H., Tromp G., Bergfeld W.F., Kay M., Helm T.N. Ehlers-Danlos syndrome type IV: a single base substitution of the last nucleotide of exon 34 in COL3A1 leads to exon skipping. J. Invest. Dermatol. 105:1995;352-356.
44. Lapiére J.-C., Woodley D.T., Parente M.G.et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera form patients with acquired epidermolysis bullosa. J. Clin. Invest. 92:1993;1831-1839.
45. Lee S., Solow-Cordero D.E., Kessler E., Takahara K., Greenspan D.S. Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J. Biol. Chem. 272:1997;19059-19066.
46. Li K., Christiano A.M., Copeland N.G.et al. cDNA cloning and chromosomal mapping of the mousetype VII collagen gene (Col7a1): evidence for rapid evolutionary divergence of the gene. Genomics. 16:1993;733-739.
47. Marinkovich M.P., Lunstrum G.P., Burgeson R.E. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J. Biol. Chem. 267:1992;17900-17906.
48. Mauviel A., Lapiére J.-C., Halcin C., Evans C.H., Uitto J. Differential cytokine regulation of type I and type VII collagen gene expression in cultured human dermal fibroblasts. J. Biol. Chem. 269:1994;25-28.
49. McGrath, J.A., Eady, R.A.J., 1994. An immunogold-EM assesment of wisp-like structures beneath the lamina densa in recessive dystrophic epidermolysis bullosa. In: Ishibashi, Y., Nakagawa, H., Suzuki, H. (Eds.), Electron Microscopy in Dermatology: Basic and Clinical Research. Elsevier Science Publishers B.V., Amsterdam, pp. 194-204.
50. Mellerio J.E., Dunnill M.G., Allison W.et al. Recurrent mutations in the type VII collagen gene (COL7A1) in patients with recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 109:1997;246-249.
51. Morris N.P., Keene D.R., Glanville R.W., Bentz H., Burgeson R.E. The tissue form of type VII collagen is an antiparallel dimer. J. Biol. Chem. 261:1986;5638-5644.
52. Nievers, M.G., Schaapveld, R.Q.J., Sonnenberg, A., this issue. Biology and Function of Hemidesmosomes.
53. Nusgens B.V., Verellen-Dumoulin Ch., Hermanns-Le T.et al. Evidence for a relationship between Ehlers-Danlos syndrome type VIIc in humans and bovine dermatosparaxis. Nat. Genet. 1:1992;214-217.
54. Pleyer U., Bruckner-Tuderman L., Friedmann A., Hartmann C., Simon J., Sterry W. The immunology of bullous oculo-muco-cutaneous disorders. Immunol. Today. 17:1996;111-113.
55. Prockop D.J., Kivirikko K.I. Collagen: molecular biology, diseases and potentials for therapy. Ann. Rev. Biochem. 64:1995;403-434.
56. Pulkkinen, L., Uitto, J., this issue. Mutation Analysis and Molecular Genetics of Epidermolysis Bullosa.
57. Raghunath M., Höpfner B., Aeschlimann D.et al. Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase. J. Clin. Invest. 98:1996;1174-1184.
58. Raghunath M., Unsöld C., Kubitscheck U., Bruckner-Tuderman L., Peters R., Meuli M. The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein-1 (LTBP-1) and is a repository for latent TGF-β J. Invest. Dermatol. 111:1998;559-564.
59. Rousselle P., Keene D.R., Ruffiero F., Champliaud M.-F., van der Rest M., Burgeson R.E. Laminin 5 binds the NC-1 domain of type VII collagen. J. Cell. Biol. 138:1997;719-728.
60. Sakuntabhai A., Hammami-Hauasli N., Bodemer L.et al. Deletions within COL7A1 exons distant from consensus splice sites alter splicing and produce shortened polypeptide in dominant dystrophic epidermolysis bullosa of carious severity. Am. J. Hum. Genet. 63:1998;737-748.
61. Salmivirta K., Sorokin L.M., Ekblom P. Differential expression of laminin alpha chains during murine tooth development. Dev. Dyn. 210:1997;206-215.
62. Shimizu H., Ishiko A., Masunaga T.et al. Most anchoring fibrils in human skin originate and terminate in the lamina densa. Lab. Invest. 76:1997;823-833.
63. Shimizu et al., unpublished.
64. Shirahama S., Furukawa F., Yagi H., Tanaka T., Hashimoto T., Takigawa M. Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen. J. Am. Acad. Dermatol. 38:1998;844-848.
65. Suzuki N., Labosky P.A., Furuta Y.et al. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development. 122:1996;3587-3595.
66. Tanaka H., Ishida-Yamamoto A., Hashimoto T.et al. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest. 77:1997;623-632.
67. Terracina M., Posteraro P., Schubert M.et al. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 111:1998;744-750.
68. Tidman M.J., Eady R.A.J. Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. J. Invest. Dermatol. 84:1985;374-377.
69. Timpl R. Macromolecular organisation of basement membranes. Curr. Opin. Cell Biol. 8:1996;618-624.
70. Vikkula M., Mariman E.C., Lui V.C.et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell. 80:1995;431-437.
71. Vindevoghel L., Kon A., Lechleider R.J., Uitto J., Roberts A.B., Mauviel A. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-beta. J. Biol. Chem. 273:1998;13053-13057.
72. Winberg J.-O., Hammami-Hauasli N., Nilssen Ö.et al. Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with different missense mutations in the COL7A1 gene. Hum. Mol. Genet. 6:1997;1125-1135.
73. Woodley D.T., Burgeson R.E., Lunstrum G., Bruckner-Tuderman L., Reese M.J., Briggaman R.A. Epidermolysis bullosa acquisita antigen is the globular carboxylterminus of type VII procollagen. J. Clin. Invest. 81:1988;683-687.
74. Yancey K. Adhesion molecules: interactions of keratinocytes with epidermal basement membrane. Arch. Dermatol. 104:1995;1008-1014.
75. Zhuang J., Tromp G., Kuivaniemi H., Nakayasu K., Prockop D.J. Deletion of 19 base pairs in intron 13 of the gene for the pro alpha 2(I) chain of type-I procollagen (COL1A2) causes exon skipping in a proband with type-I osteogenesis imperfecta. Hum. Genet. 91:1993;210-216.